Digital imaging of suspected skin cancers has dramatically cut waiting times for diagnosis and treatment in Nottinghamshire.

Patel, MD, director of cutaneous oncology at the George Washington (GW) Cancer Center, director of dermatologic surgery at the GW University School of Medicine and Health Sciences, and associate ...

As the human body's largest organ, it's no surprise that an endless number of things can go wrong with your skin.There are the lumps and bumps that can appear out of nowhere.

Based on several lines of interesting data, the authors conclude that FMRP, though associated with stalled ribosomes, does not determine the position on the mRNAs at which ribosomes stall. Although ...

Prognosis: Removal typically cures the cancer. Most SCCs are slow-growing, though this type of skin cancer is more likely to grow deeper into the skin and spread. If SCCs spread to other organs, ...

CHANCES ARE, ONE out of five of you reading this will be diagnosed with skin cancer by the time you hit age 70. As the most ...

Basal cell carcinoma is a type of skin cancer that originates from the basal cells, which are cells within the skin that produce “new skin cells as old ones die off,” according to Mayo Clinic.

Grob JJ, Gaudy-Marqueste C, Guminski A, et al. Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas.

Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial). Nature Cancer, 2025; DOI: 10.1038/s43018-024-00879-x ...

Ressler, J. M., et al. (2025) Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial). Nature Cancer. doi ...

Basal Cell Carcinoma Market Outlook 2025-2035: The basal cell carcinoma market reached a value of USD 5.48 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 9.70 Billion by ...